Learn more about whether Revvity, Inc. or 10x Genomics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Learn about comparative gene expression studies in Alzheimer's disease and other conditions in Mayo Clinic's Precision Medicine in Neurodegeneration Lab.

CareDx CDNA announced the launch of VANTx, an AI-driven, cloud-based clinical data and analytics platform. The platform is designed to convert complex transplant datasets into insights that support ...

Scientists have discovered that cells can sense far beyond the surfaces they touch. While individual cancer cells can probe about 10 microns ahead by tugging on surrounding collagen fibers, clusters ...

In a single experiment, scientists can decipher the entire genomes of many patient samples, animal models, or cultured cells.

Researchers have developed a capsule-based method that makes it possible to analyze the same cell through multiple experimental steps. The technology overcomes a long-standing limitation in cell ...

In this webinar, Stefan Radtke will discuss the development of new high-throughput single-cell readouts for precise and comprehensive tracking of gene editing outcomes after autologous hematopoietic ...

Researchers have developed a capsule-based method that makes it possible to analyse the same cell through multiple experimental steps. The technology overcomes a long-standing limitation in cell ...

Cancer is caused by faulty genes, but what also shapes a cancer cell's behavior is how a gene's instructions are trimmed and ...

Tempus peers such as Inspire Medical Systems INSP and 10x Genomics TXG are also expected to maintain growth momentum heading into 2026. While Inspire Medical Systems continues to benefit from rising ...

As routine labs, imaging, and information from wearables and the environment stream in, a digital twin can model trajectories ...